Logo image of CALB

CALIFORNIA BANCORP INC (CALB) Stock Fundamental Analysis

NASDAQ:CALB - US13005U1016 - Common Stock

25.09 USD
+0.26 (+1.05%)
Last: 7/31/2024, 8:25:52 PM
25.09 USD
0 (0%)
After Hours: 7/31/2024, 8:25:52 PM
Fundamental Rating

3

Overall CALB gets a fundamental rating of 3 out of 10. We evaluated CALB against 395 industry peers in the Banks industry. There are concerns on the financial health of CALB while its profitability can be described as average. CALB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

CALB had positive earnings in the past year.
In the past year CALB had a positive cash flow from operations.
CALB had positive earnings in each of the past 5 years.
CALB had a positive operating cash flow in each of the past 5 years.
CALB Yearly Net Income VS EBIT VS OCF VS FCFCALB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

1.2 Ratios

The Return On Assets of CALB (1.04%) is better than 67.24% of its industry peers.
With a decent Return On Equity value of 9.97%, CALB is doing good in the industry, outperforming 64.04% of the companies in the same industry.
Industry RankSector Rank
ROA 1.04%
ROE 9.97%
ROIC N/A
ROA(3y)0.93%
ROA(5y)0.72%
ROE(3y)10.71%
ROE(5y)8.13%
ROIC(3y)N/A
ROIC(5y)N/A
CALB Yearly ROA, ROE, ROICCALB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

CALB has a better Profit Margin (25.32%) than 62.07% of its industry peers.
In the last couple of years the Profit Margin of CALB has grown nicely.
CALB does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 25.32%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y45.8%
PM growth 5Y4.34%
GM growth 3YN/A
GM growth 5YN/A
CALB Yearly Profit, Operating, Gross MarginsCALB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

More info and screens

2

2. Health

2.1 Basic Checks

CALB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CALB has been increased compared to 1 year ago.
CALB has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CALB is higher compared to a year ago.
CALB Yearly Shares OutstandingCALB Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
CALB Yearly Total Debt VS Total AssetsCALB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

CALB has a debt to FCF ratio of 2.70. This is a good value and a sign of high solvency as CALB would need 2.70 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.70, CALB is in line with its industry, outperforming 50.74% of the companies in the same industry.
CALB has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
CALB has a Debt to Equity ratio of 0.27. This is comparable to the rest of the industry: CALB outperforms 44.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 2.7
Altman-Z N/A
ROIC/WACCN/A
WACC13.7%
CALB Yearly LT Debt VS Equity VS FCFCALB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CALB Yearly Current Assets VS Current LiabilitesCALB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

3

3. Growth

3.1 Past

CALB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -63.99%.
The Earnings Per Share has been growing by 16.55% on average over the past years. This is quite good.
CALB shows a decrease in Revenue. In the last year, the revenue decreased by -6.93%.
Measured over the past years, CALB shows a quite strong growth in Revenue. The Revenue has been growing by 14.97% on average per year.
EPS 1Y (TTM)-63.99%
EPS 3Y57.12%
EPS 5Y16.55%
EPS Q2Q%-206.15%
Revenue 1Y (TTM)-6.93%
Revenue growth 3Y17.53%
Revenue growth 5Y14.97%
Sales Q2Q%-7.28%

3.2 Future

CALB is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -10.13% yearly.
CALB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.01% yearly.
EPS Next Y-19.79%
EPS Next 2Y-10.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.26%
Revenue Next 2Y1.01%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CALB Yearly Revenue VS EstimatesCALB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
CALB Yearly EPS VS EstimatesCALB Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 24.36 indicates a rather expensive valuation of CALB.
Compared to the rest of the industry, the Price/Earnings ratio of CALB indicates a rather expensive valuation: CALB more expensive than 83.25% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of CALB to the average of the S&P500 Index (26.90), we can say CALB is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 12.14, the valuation of CALB can be described as correct.
Based on the Price/Forward Earnings ratio, CALB is valued a bit more expensive than the industry average as 62.32% of the companies are valued more cheaply.
CALB's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.52.
Industry RankSector Rank
PE 24.36
Fwd PE 12.14
CALB Price Earnings VS Forward Price EarningsCALB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CALB's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 10.57
EV/EBITDA N/A
CALB Per share dataCALB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

A cheap valuation may be justified as CALB's earnings are expected to decrease with -10.13% in the coming years.
PEG (NY)N/A
PEG (5Y)1.47
EPS Next 2Y-10.13%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CALB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CALIFORNIA BANCORP INC

NASDAQ:CALB (7/31/2024, 8:25:52 PM)

After market: 25.09 0 (0%)

25.09

+0.26 (+1.05%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-29 2024-07-29/bmo
Earnings (Next)10-24 2024-10-24/amc
Inst Owners0.88%
Inst Owner Change0%
Ins Owners1.85%
Ins Owner Change0%
Market Cap212.51M
Analysts82.5
Price Target23.46 (-6.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.45%
Min EPS beat(2)-18.15%
Max EPS beat(2)1.25%
EPS beat(4)3
Avg EPS beat(4)-2.13%
Min EPS beat(4)-18.15%
Max EPS beat(4)7.4%
EPS beat(8)6
Avg EPS beat(8)4.28%
EPS beat(12)9
Avg EPS beat(12)7.87%
EPS beat(16)12
Avg EPS beat(16)18.26%
Revenue beat(2)0
Avg Revenue beat(2)-2.02%
Min Revenue beat(2)-2.46%
Max Revenue beat(2)-1.57%
Revenue beat(4)0
Avg Revenue beat(4)-2.31%
Min Revenue beat(4)-3.52%
Max Revenue beat(4)-1.57%
Revenue beat(8)3
Avg Revenue beat(8)0.59%
Revenue beat(12)5
Avg Revenue beat(12)0.48%
Revenue beat(16)8
Avg Revenue beat(16)1.29%
PT rev (1m)-10%
PT rev (3m)-16.76%
EPS NQ rev (1m)-0.44%
EPS NQ rev (3m)-5.42%
EPS NY rev (1m)-1.42%
EPS NY rev (3m)-9.23%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)-2.4%
Revenue NY rev (1m)-0.51%
Revenue NY rev (3m)-2.2%
Valuation
Industry RankSector Rank
PE 24.36
Fwd PE 12.14
P/S 2.69
P/FCF 10.57
P/OCF 10.54
P/B 1.06
P/tB 1.1
EV/EBITDA N/A
EPS(TTM)1.03
EY4.11%
EPS(NY)2.07
Fwd EY8.24%
FCF(TTM)2.37
FCFY9.46%
OCF(TTM)2.38
OCFY9.49%
SpS9.33
BVpS23.69
TBVpS22.82
PEG (NY)N/A
PEG (5Y)1.47
Profitability
Industry RankSector Rank
ROA 1.04%
ROE 9.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 25.32%
GM N/A
FCFM 25.46%
ROA(3y)0.93%
ROA(5y)0.72%
ROE(3y)10.71%
ROE(5y)8.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y45.8%
PM growth 5Y4.34%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 2.7
Debt/EBITDA N/A
Cap/Depr 6.07%
Cap/Sales 0.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 100.57%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC13.7%
ROIC/WACCN/A
Cap/Depr(3y)9.99%
Cap/Depr(5y)110.48%
Cap/Sales(3y)0.2%
Cap/Sales(5y)2.66%
Profit Quality(3y)128.31%
Profit Quality(5y)158.55%
High Growth Momentum
Growth
EPS 1Y (TTM)-63.99%
EPS 3Y57.12%
EPS 5Y16.55%
EPS Q2Q%-206.15%
EPS Next Y-19.79%
EPS Next 2Y-10.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.93%
Revenue growth 3Y17.53%
Revenue growth 5Y14.97%
Sales Q2Q%-7.28%
Revenue Next Year-1.26%
Revenue Next 2Y1.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y64.46%
FCF growth 3Y35.75%
FCF growth 5Y23.39%
OCF growth 1Y63.05%
OCF growth 3Y24.11%
OCF growth 5Y23.46%